Kershner QI Award Winners

Consistent and sustained reduction in surgical site infections from 1.684% to zero

43% reduction in sharps and biomedical waste generated from the facility, exceeding the goal of a 25% reduction

Saved $70 per unit by switching from Miochol to Miostat for $27K annual savings 

Resulted in 20% improvement in written orders for a scopolamine patch to prevent postoperative nausea and vomiting

Obtained 100% compliance with national guidelines on terminally sterilizing all surgical implants

Reduced the fluctuations in blood sugar among diabetic patients by 63%

Reduced the ciprofloxacin or cephalosporin-related reactions to zero; saving >$2K in reduced ciprofloxacin purchased

Number of sharps injuries decreased from 2-4 per year to zero

Increased patient safety by switching from IV sedation with opiates to oral sedation which lowers risk of patient complications

Treatment rate of students for uncomplicated Acute Bronchitis without
the use of antibiotics, increased from 37% to 89%

7% increase in measles vaccination rates for children 3-18 years old

Generated a 33% decrease in readmission rates due to the medication reconciliation and transition of care program

Resulted in 92%of students eligible for alcohol screening completing the AUDIT-C; offered 91% of students identified as binge drinkers a brief motivational intervention

Resulted in 98% of woman under 21 receiving a pap test; 21% improvement over the previous rate of 77%

Achieved 13% increase in documentation of STI risk factors and discussion of HIV testing and prevention counseling (77% to 90%)

More than 90% of identified patients were receiving treatment within 4 weeks and 50% of students demonstrated a functional recovery at 12 weeks

Increase in documentation of ADEs from an average of 129 to 360 per year

The rate of HBV vaccination/vaccine counseling for the four criteria described increased from 69% to 94%